How the Rare Cancers Bill Could Help Brain Tumour Research
A Step Forward for Rare Cancer Research in the UK
Rare Cancers Bill to Become Law: What It Means for Brain Tumour Research
The Rare Cancers Bill could mark an important step forward for brain tumour research in the UK. If passed into law, it may help improve coordination across rare cancer research, strengthen access to clinical trials, and increase support for patients living with brain tumours and other rare cancers.
The Rare Cancers Bill has now passed its Third Reading in the House of Lords and is moving towards Royal Assent. This marks an important development for rare cancer research, including progress for brain tumour research and improved access to clinical trials.
For families affected by brain tumours, this legislation represents a step forward in addressing long-standing challenges around research funding, treatment development and access to innovative care.
Types of Brain Tumours
Early diagnosis matters.
What is the Rare Cancers Bill Brain Tumour Research?
The Rare Cancers Bill is proposed UK legislation aimed at improving how rare cancers are researched and supported. For brain tumour patients, this matters because rare cancers often receive less funding, fewer clinical trial opportunities, and slower progress in treatment development.
Brain Tumours as Rare Cancers
Why the Rare Cancers Bill Matters for Brain Tumour Research & Patients
Brain tumours are often classified as rare cancers, which means research, drug development and clinical trial access can be more limited compared to more common cancers.
The Rare Cancers Bill aims to:
Improve coordination of rare cancer research across the UK
Strengthen data collection and collaboration
Review how orphan drugs are assessed and approved
Support better access to clinical trials for rare cancer patients
For people living with a brain tumour diagnosis, easier access to clinical trials and targeted treatments could play a vital role in improving outcomes and quality of life.
Removing Barriers to Clinical Trial Access
How the Bill Could Improve Access to Clinical Trials & New Treatments
One of the key areas highlighted within the Rare Cancers Bill is improving access to innovative treatments and research opportunities.
Patients with brain tumours have often faced barriers when trying to access clinical trials, whether due to geographical limitations, inconsistent data systems or delays in trial approval processes. By creating a stronger national focus on rare cancers, the Bill aims to remove some of these obstacles.
Increased coordination may also help ensure that promising treatments are assessed more efficiently, potentially bringing new options to patients sooner.
Making a Difference Together
Support Families Affected by Brain Tumours
Better research matters. However, families also need clear advice, support and community right now. Explore our Help & Advice page or support our work today.
Charity and Community Involvement in the Rare Cancers Bill
The Role of Advocacy and Collaboration in Brain Tumour Research
Charities like ours, The Three Tumours, The Brain Tumour Charity and Brain Tumour Research have supported the progression of this legislation, working alongside the Bill’s sponsor, Dr Scott Arthur MP, to ensure that the voices of rare cancer patients were represented throughout the parliamentary process.
This collaboration highlights the importance of advocacy in driving policy change for the brain tumour community.
Dr Scott Arthur, MP
Long-Term Impact of the Rare Cancers Bill
What Happens Next for Brain Tumour Research?
While the Rare Cancers Bill becoming law does not mean immediate change, it lays important groundwork for improving rare cancer research and treatment access in the years ahead.
Progress in brain tumour research takes time, but legislative commitments such as this demonstrate growing recognition of the need for better support, funding and innovation.
We will continue to monitor developments and advocate for meaningful change for families affected by brain tumours.
Living with a Brain Tumour: Where to Find the Right Support
How Families Affected by Brain Tumours Can Find Support
At The Three Tumours, we provide support, education, and connection for people living with all types of brain tumours. Whether you are newly diagnosed, living with long-term effects, or supporting a loved one, we are here to help. Learn more about symptoms, coping strategies, and our support services here:
Your questions, answered simply
The Three Tumours, A Brain Tumour Charity - FAQ
Start here: quick, helpful answers from our brain tumour charity.
If you still have questions, please do get in touch.
What is the Rare Cancers Bill?
The Rare Cancers Bill is proposed UK legislation designed to improve research, coordination and support for people affected by rare cancers, including brain tumours.
Why does the Rare Cancers Bill matter for brain tumour research?
Brain tumours are often classed as rare cancers, which can mean less funding and fewer clinical trial opportunities. The bill could help improve research focus and treatment access.
Could the Rare Cancers Bill improve access to clinical trials?
Yes, one of the aims is to improve coordination and reduce barriers that can make clinical trial access harder for rare cancer patients.
Will the Rare Cancers Bill immediately change treatment for brain tumour patients?
Not straight away. However, it could create stronger long-term support for research, innovation and future treatment development.
How can I support brain tumour research and awareness?
You can support awareness, fundraising and family support through The Three Tumours, while also helping keep pressure on progress in brain tumour research.
